The landscape of dementia analysis has advanced drastically with the appearance of advanced biomarkers, like amyloid PET scans, tau imaging, and blood-centered tests that could detect Alzheimer's pathology decades before signs arise. When these technological innovations signify exceptional progress in comprehension neurodegenerative disorders, they